Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 19 | 2024 | 131 | 11.610 |
Why?
|
| Surgeons | 3 | 2024 | 238 | 1.740 |
Why?
|
| Surgery, Plastic | 2 | 2020 | 42 | 1.360 |
Why?
|
| Consumer Health Information | 1 | 2023 | 13 | 0.940 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2023 | 23 | 0.900 |
Why?
|
| Antifibrinolytic Agents | 1 | 2023 | 30 | 0.880 |
Why?
|
| Mediastinal Emphysema | 1 | 2022 | 6 | 0.870 |
Why?
|
| Hemostatics | 1 | 2023 | 56 | 0.870 |
Why?
|
| Facial Nerve Injuries | 1 | 2022 | 10 | 0.870 |
Why?
|
| Facial Injuries | 1 | 2022 | 19 | 0.870 |
Why?
|
| Blast Injuries | 1 | 2022 | 11 | 0.860 |
Why?
|
| Anti-Infective Agents | 1 | 2023 | 89 | 0.850 |
Why?
|
| Critical Care | 2 | 2024 | 370 | 0.850 |
Why?
|
| Shock, Septic | 1 | 2023 | 102 | 0.840 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2021 | 22 | 0.830 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2021 | 30 | 0.830 |
Why?
|
| Burn Units | 4 | 2023 | 21 | 0.800 |
Why?
|
| Compartment Syndromes | 1 | 2021 | 12 | 0.790 |
Why?
|
| Intraocular Pressure | 1 | 2021 | 54 | 0.780 |
Why?
|
| Orbital Diseases | 1 | 2021 | 21 | 0.780 |
Why?
|
| Bone Nails | 1 | 2020 | 17 | 0.750 |
Why?
|
| Mastectomy, Segmental | 1 | 2018 | 92 | 0.600 |
Why?
|
| Family Practice | 1 | 2017 | 84 | 0.590 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 166 | 0.580 |
Why?
|
| Mammaplasty | 1 | 2018 | 105 | 0.550 |
Why?
|
| Retrospective Studies | 10 | 2023 | 8477 | 0.540 |
Why?
|
| Emergency Medicine | 1 | 2017 | 123 | 0.540 |
Why?
|
| Length of Stay | 4 | 2023 | 700 | 0.530 |
Why?
|
| Referral and Consultation | 1 | 2018 | 326 | 0.510 |
Why?
|
| Humans | 24 | 2024 | 86617 | 0.510 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 454 | 0.490 |
Why?
|
| Primary Health Care | 1 | 2017 | 339 | 0.470 |
Why?
|
| Bandages | 2 | 2024 | 41 | 0.470 |
Why?
|
| Cleft Lip | 1 | 2013 | 15 | 0.460 |
Why?
|
| Cleft Palate | 1 | 2013 | 25 | 0.450 |
Why?
|
| Indians, North American | 1 | 2013 | 48 | 0.450 |
Why?
|
| Canada | 3 | 2020 | 204 | 0.440 |
Why?
|
| Hospitalization | 4 | 2023 | 849 | 0.420 |
Why?
|
| Clinical Competence | 1 | 2017 | 751 | 0.410 |
Why?
|
| Surveys and Questionnaires | 4 | 2022 | 2501 | 0.400 |
Why?
|
| Internship and Residency | 1 | 2020 | 1004 | 0.390 |
Why?
|
| Adolescent | 4 | 2023 | 8979 | 0.330 |
Why?
|
| Child | 4 | 2023 | 6926 | 0.320 |
Why?
|
| Adult | 9 | 2023 | 25640 | 0.320 |
Why?
|
| Blood Loss, Surgical | 2 | 2023 | 112 | 0.270 |
Why?
|
| Female | 8 | 2023 | 44509 | 0.260 |
Why?
|
| Young Adult | 3 | 2023 | 5974 | 0.250 |
Why?
|
| Autografts | 1 | 2024 | 28 | 0.240 |
Why?
|
| APACHE | 1 | 2023 | 21 | 0.240 |
Why?
|
| Water | 2 | 2023 | 277 | 0.240 |
Why?
|
| Male | 6 | 2023 | 40958 | 0.240 |
Why?
|
| Beverages | 1 | 2023 | 17 | 0.230 |
Why?
|
| Administration, Topical | 1 | 2023 | 95 | 0.230 |
Why?
|
| Comprehension | 1 | 2023 | 79 | 0.220 |
Why?
|
| Vasoconstrictor Agents | 1 | 2023 | 53 | 0.220 |
Why?
|
| Cheek | 1 | 2022 | 22 | 0.220 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 1621 | 0.210 |
Why?
|
| Hair | 1 | 2022 | 56 | 0.210 |
Why?
|
| Language | 1 | 2023 | 151 | 0.210 |
Why?
|
| Body Surface Area | 1 | 2021 | 36 | 0.210 |
Why?
|
| Research Report | 1 | 2022 | 44 | 0.200 |
Why?
|
| Frailty | 1 | 2022 | 58 | 0.200 |
Why?
|
| Internet | 1 | 2023 | 312 | 0.200 |
Why?
|
| Physical Abuse | 1 | 2020 | 4 | 0.190 |
Why?
|
| Los Angeles | 1 | 2020 | 28 | 0.190 |
Why?
|
| Decompression, Surgical | 1 | 2021 | 87 | 0.190 |
Why?
|
| Resuscitation | 1 | 2021 | 100 | 0.190 |
Why?
|
| Hypoglycemia | 1 | 2021 | 107 | 0.190 |
Why?
|
| Prognosis | 3 | 2023 | 3675 | 0.180 |
Why?
|
| Enteral Nutrition | 1 | 2020 | 102 | 0.180 |
Why?
|
| Intraoperative Care | 1 | 2020 | 82 | 0.180 |
Why?
|
| Patient Positioning | 1 | 2020 | 63 | 0.180 |
Why?
|
| Infant | 2 | 2023 | 3045 | 0.180 |
Why?
|
| Wound Healing | 1 | 2021 | 344 | 0.170 |
Why?
|
| Operating Rooms | 1 | 2020 | 126 | 0.170 |
Why?
|
| Motivation | 1 | 2022 | 287 | 0.170 |
Why?
|
| United States | 2 | 2022 | 6665 | 0.170 |
Why?
|
| Age Factors | 1 | 2023 | 1849 | 0.170 |
Why?
|
| Self-Injurious Behavior | 1 | 2020 | 105 | 0.160 |
Why?
|
| Esthetics | 1 | 2018 | 44 | 0.160 |
Why?
|
| Critical Illness | 1 | 2020 | 294 | 0.150 |
Why?
|
| Middle Aged | 4 | 2023 | 25017 | 0.150 |
Why?
|
| Personnel Selection | 1 | 2018 | 59 | 0.150 |
Why?
|
| Carcinoma, Lobular | 1 | 2018 | 80 | 0.150 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 111 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2020 | 371 | 0.150 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 369 | 0.140 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2018 | 156 | 0.140 |
Why?
|
| Self Report | 1 | 2018 | 288 | 0.140 |
Why?
|
| Child, Preschool | 1 | 2023 | 3611 | 0.140 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1801 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2705 | 0.130 |
Why?
|
| General Surgery | 1 | 2018 | 228 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 3636 | 0.120 |
Why?
|
| Aged | 4 | 2022 | 18402 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2020 | 2767 | 0.120 |
Why?
|
| Treatment Refusal | 1 | 2012 | 60 | 0.110 |
Why?
|
| Complementary Therapies | 1 | 2012 | 54 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2887 | 0.100 |
Why?
|
| Women's Health | 1 | 2012 | 100 | 0.100 |
Why?
|
| Rhombencephalon | 1 | 2009 | 50 | 0.090 |
Why?
|
| Registries | 1 | 2013 | 702 | 0.090 |
Why?
|
| Respiratory Center | 1 | 2009 | 53 | 0.090 |
Why?
|
| Prevalence | 1 | 2013 | 1239 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 314 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6501 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2013 | 2378 | 0.070 |
Why?
|
| Epinephrine | 1 | 2022 | 84 | 0.050 |
Why?
|
| Skin Transplantation | 1 | 2022 | 172 | 0.050 |
Why?
|
| Energy Intake | 1 | 2020 | 98 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2022 | 349 | 0.050 |
Why?
|
| Inpatients | 1 | 2022 | 297 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 378 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 373 | 0.040 |
Why?
|
| Risk Factors | 1 | 2023 | 5417 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2012 | 229 | 0.030 |
Why?
|
| Adenosine A1 Receptor Agonists | 1 | 2009 | 1 | 0.020 |
Why?
|
| Adenosine A1 Receptor Antagonists | 1 | 2009 | 4 | 0.020 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2009 | 15 | 0.020 |
Why?
|
| 5'-Nucleotidase | 1 | 2009 | 13 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2009 | 55 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 429 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2009 | 135 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2009 | 87 | 0.020 |
Why?
|
| Periodicity | 1 | 2009 | 119 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2009 | 97 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2009 | 510 | 0.020 |
Why?
|
| Respiration | 1 | 2009 | 262 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1577 | 0.020 |
Why?
|
| Adenosine | 1 | 2009 | 225 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1219 | 0.020 |
Why?
|
| Action Potentials | 1 | 2009 | 573 | 0.020 |
Why?
|
| Rats | 1 | 2009 | 3990 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 7990 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 26582 | 0.010 |
Why?
|